NCT07040865View on ClinicalTrials.gov

Randomized Comparison of Contrast Agents Gadopiclenol and Gadobutrol in the Workup of Incidental Renal and Adrenal Findings

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

July 31, 2027

Conditions
Suspect Renal and Adrenal Imaging Findings
Interventions
DRUG

Gadobutrol (Gadovist/Gadavist)

Magnetic resonance acquisition without contrast agent followed the same acquisition 60 s and 15 min after gadobutrol contrast injection.

DRUG

Gadopiclenol

Magnetic resonance acquisition without contrast agent followed the same acquisition 60 s and 15 min after gadopiclenol contrast injection.

Trial Locations (1)

3010

Department of Diagnostic, Interventional and Pediatric Radiology Inselspital, University of Bern, Bern

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER